October 2019 - Page 21 of 28

WednesdayOct 09, 2019 12:33 pm

Neutra Corp. (NTRR) Prepares to Introduce CBD-Based Pain Relief for Athletes

As consumers have become increasingly health conscious as a fitness-interested segment of society, holistic-oriented wellness products have gained a parallel footing as alternatives to prescription drugs The trend is exemplified by the recent explosion of interest in cannabis-based products that don’t have marijuana’s drug qualities but do have muscle pain and spasm relieving properties Neutra Corp is preparing to introduce a transdermal pain-relief cream based on a CBD formulation designed to benefit athletes whose workouts induce aches and pains The CBD market is expected to top $1 billion in sales by 2022, a result of the growing interest and opportunity…

WednesdayOct 09, 2019 11:50 am

Predictive Oncology Inc. (NASDAQ: POAI) Inks its Largest Single-Hospital Sale of Revolutionary STREAMWAY(R) System

POAI recently announced the sale of 10 FDA-approved, CE-marked STREAMWAY Systems STREAMWAY Systems are the first truly continuous, direct-to drain fluid-disposal solutions designed specifically for medical applications The announcement is another positive indication that POAI subsidiary Skyline Medical offers tremendous qualitative, long-term potential In a significant announcement that bodes well for the company, Predictive Oncology Inc. (NASDAQ: POAI) announced that its Skyline Medical Division, producer of the STREAMWAY(R) System, has completed the sale of 10 systems to a major New York hospital (http://ibn.fm/dXHwp). The sale exceeds POAI’s largest single-hospital sale to date, and it is anticipated that the systems collectively will handle…

WednesdayOct 09, 2019 10:40 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) DehydraTECH Featured in Human CBD Study Results Published in Clinical Journal

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug-delivery platforms, announced that final study results of a 2018 clinical study evaluating the use of its proprietary drug-delivery system have been published (http://ibn.fm/AYzRL) (http://ibn.fm/PfnAA). Published in Advances in Therapy, a peer-reviewed medical journal, the human clinical study evaluated CBD delivery and effectiveness using LXRP-patented, DehydraTECH(TM)-powered TurboCBD(TM) capsules. Key findings highlighted in the publication included the following: CBD in-plasma levels with the TurboCBD 90 mg dose were significantly higher than with the generic 90 mg dose at both 90 and 120 minutes (p < 0.05); Only the TurboCBD 90 mg…

WednesdayOct 09, 2019 10:20 am

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) Lights Up NACS with Launch of Pure American Hemp(TM) Cigarettes

Technology and investment company SinglePoint (OTCQB: SING) today announced major success at the 2019 National Association of Convenience Stores show (“NACS”) in Atlanta. SinglePoint, as the master distributor of Pure American Hemp(TM) Cigarettes, sold multiple cases to retail store owners representing approximately 2500 stores during the show. In addition, SinglePoint was able to directly interact with interested store owners, national distributors and buying groups, accounting for well over 20,000 retail locations and, this week, has ordered additional product to meet demand. “Our success at NACS was beyond what anybody in our group imagined. It truly gave us deep insight to…

WednesdayOct 09, 2019 9:58 am

ORHub Inc. (ORHB) Optimizes the Business of Surgery Through Proprietary Analytics Product Surgical Spotlight

ORHub, a Microsoft Silver Partner, leverages the Azure cloud to help perioperative leaders unlock the power of health care data captured in the operating room Surgical Spotlight®, a cloud-based analytics tool, helps spot trends and outliers with curated performance indicators, increasing efficiency, decreasing costs and improving patient access in the operating room The global health care analytics market is projected to reach $50 billion by 2024, with a five-year CAGR of 28.3 percent from 2019 Chief Executive Officer Dr. Robert ‘Bobby’ Lazzara is a renowned cardiac surgeon and founder of Medical News Minute ORHub Inc. (OTC: ORHB), a cloud-based health…

WednesdayOct 09, 2019 9:44 am

QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Announces Plans to Present at Inaugural MicroCap Rodeo Investor Conference

Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) today announced its plans to present at the upcoming inaugural MicroCap Rodeo Investor Conference to be held at the Hilton Austin - Downtown in Austin, Texas. Genprex’s presentation is scheduled to take place on Tuesday, October 15 at 9:10 a.m. Central Time, led by its Chairman and CEO Rodney Varner, who will also be available for one-on-one meetings with investors. In addition, the presentation will be available via live webcast, with an archived recording to be provided for later viewing. To view the full press release, visit http://ibn.fm/uOnzL About Genprex, Inc. Genprex, Inc.…

WednesdayOct 09, 2019 9:35 am

QualityStocksNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Posts Credit Financing Update

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified-organic cannabis, today announced that it is reviewing alternative financing options to complete construction at its facilities in Ancaster, Ontario and phase 1a at Valleyfield, Quebec. Per the update, TGODF’s previously disclosed discussions for ordinary course commercial bank facilities and equipment leasing are no longer available on the acceptable terms within the timeframes required due to changing market conditions. Presently, the company has no debt and $56.7 million in cash available in Canada, including $40.2 million in restricted cash allocated to capital expenditures. Construction at Ancaster…

TuesdayOct 08, 2019 1:39 pm

Predictive Oncology Inc. (NASDAQ: POAI) Continues to Innovate to Improve Outcomes for Cancer Patients

POAI is leveraging the potential of AI and smart tumor profiling to predict tumor drug response TumorGenesis is developing innovative techniques for growing tumors in laboratory settings Helomics uses vital information from patients’ own living tumors to assist oncologists in selecting the most effective treatments Predictive Oncology Inc. (NASDAQ: POAI) is harnessing the power of artificial intelligence (AI) and rich information from patients’ own tumors to improve outcomes for cancer patients. Predictive Oncology applies its proprietary smart tumor profiling and AI platform to extensive genomic and biomarker patient datasets in order to predict tumor drug response and improve clinical outcomes…

TuesdayOct 08, 2019 11:19 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Riding High on Potential Cannabis, Nicotine Uses of Patented Technology

Lexaria Bioscience is helping to revolutionize efforts to provide common drug substances in an ingestible method that avoids unhealthy practices such as inhaled smoking or vaping Lexaria’s DehydraTECH platform works to deliver the chemical compounds to the blood stream at speeds comparable to inhalation methods, providing the means for discrete use and avoiding frustrating waits for users with dependencies The company recently obtained a patent in Australia that recognizes DehydraTECH not only as a food and beverage platform, but also as a potential means of pharmaceutical use for combatting select illnesses As Canada prepares to introduce legalization of cannabis food…

Site Search

Company Search

Month: October 2019